Alcohol is one of the most dangerous drugs, yet its presence is ubiquitous in social settings and celebrations 
Solidigm Eyes $150 Billion IPO as SK Hynix Expands AI Storage Push 
Booked to travel through the Middle East? Here’s why you shouldn’t cancel your flight 
Stuck in a creativity slump at work? Here are some surprising ways to get your spark back 
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion 
OpenAI Agent Breaches Australia Medicare Data Portal 
What is Zionism? The different meanings of a contested term 
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline 
Yes, government influences wages – but not just in the way you might think 
Disaster or digital spectacle? The dangers of using floods to create social media content 
Time to buy local: war fuel price shocks reveal the folly of a long food supply chain 
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+ 
The ghost of Robodebt – Federal Court rules billions of dollars in welfare debts must be recalculated 
Oil Prices Ease as Iran Tensions Clash With Diplomacy Hopes 
‘Buy now, pay later’ doesn’t feel like debt. For young people, that can be a big problem 
US Backs Musk in Fight Against EU’s €120 Million X Fine 
Add as a preferred source on Google
Coca-Cola Japan and Kirin Holdings will develop health drinks that contain the live bacteria, lactococcus lactis strain plasma (LC-Plasma), an ingredient patented by Kirin that is used in the company's health drinks.
Kirin claims that the live bacteria boosts immunity in healthy people.
Kirin is the first among companies that make foods and beverages they claim to boost immunity to have been approved by Japan's Consumer Affairs Agency in 2020 to advertise its products as such.
Coca-Cola Japan plans to put LC-Plasma into three of its brands, Georgia, Irohasu, and Minute Maid.
The Consumer Affairs Agency has also given the go-ahead for the drinks to be advertised as having the advantage.
The partnership demonstrates Coca-Cola Japan's intention to improve its position in the health beverage market. According to market research firm Inryo Soken, Coca-Cola has a 26 percent market share in soft drinks but has not advanced significantly in the market for health beverages.
On the other hand, Kirin is increasing sales of its LC-Plasma component and sees health products as its next area of growth. It anticipates that by 2027, sales of health drinks will have increased fivefold from their current level to 50 billion yen.
Taisho Pharmaceutical Holdings, as well as candy manufacturers including Morinaga & Co. and Kanro, have already purchased the component from Kirin.
Although supplying a rival with distinctive ingredients would negate Kirin's advantage, collaborating with Coca-Cola might let it expand its market.
